Drug Approval | September 28, 2024
FDA approves Bristol Myers Squibb’s Cobenfy
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
Potential of Ayurveda’s contribution in global health system through various innovative practices
India has taken the lead in recognising NAFLD as a major non-communicable disease
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
Subscribe To Our Newsletter & Stay Updated
